Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
3.520
+0.050 (1.44%)
Sep 15, 2025, 1:05 PM EDT - Market open
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $1.24 billion as of September 15, 2025. Its market cap has decreased by -3.53% in one year.
Market Cap
1.24B
Enterprise Value
1.38B
1-Year Change
-3.53%
Ranking
Category
Stock Price
$3.52
Market Cap Chart
Since the IPO on November 2, 2010, Evotec SE's market cap has increased from $366.30M to $1.24B, an increase of 239.20%. That is a compound annual growth rate of 8.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 1.21B | -19.68% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | 38.57% |
| Dec 30, 2020 | 6.08B | 56.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |